Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 96 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
951 12.0 months Metastatic breast cancer 5 Chemotherapy
Applied Cancer Research-Institution for Translational Research Vienna Austria 2/2008
Treatment Details: Patients: This phase II study involved eighty-seven women with metastatic breast cancer. The majority had received chemotherapy and/or hormonal therapy. Treatment: Patients were treate
 
952 12.0 months NSCLC 5 Chemotherapy
Taipei Veterans General Hospital, School of Medicine, National Yang-Ming University Taiwan Region 8/2008
Treatment Details: Patients: This phase 2 study involved 65 patients with non-small cell lung cancer. They had not received chemotherapy before being in this study. These patients ranged in age from 70 to 8
 
953 12.0 months Metastatic breast cancer 3 Biologic therapy
Chemotherapy
Saint Savas Oncology Hospital Greece 4/2008
Treatment Details: Patients: This study involved 22 women with metastatic breast cancer. The median age was 56, ranging from 32 to 73 years of age. Treatment: Patients were treated with the biological ther
 
954 12.0 months Recurrent, platinum-resistant epithelial ovarian cancer 4 Biologic therapy
Dana-Farber Cancer Institute United States 1/2013
Treatment Details: Patients: This phase 2 study involved 64 patients with recurrent, platinum-resistant epithelial ovarian cancer (patients had been previously treated with platinum-containing therapy). The
 
955 12.0 months Advanced hepatocellular cancer 5 Biologic therapy
Massachusetts General Hospital Cancer Center United States 12/2013
Treatment Details: Patients: This phase 2 study involved 42 advanced hepatocellular cancer patients. The median patient age was 63 years and 81% were male. Treatment: Patients were treated with the biolo
 
956 12.0 months Advanced bladder cancer 4 Chemotherapy
Zagazig University Egypt 1/2014
Treatment Details: Patients: This phase 2 study involved 60 advanced bladder cancer patients who were not previously treated. The median patient age was 60 years and 73.3% were male. Treatment: Patients
 
957 12.0 months Metastatic colorecal cancer 4 Chemotherapy
Rocky Mountain Cancer Center United States 3/2013
Treatment Details: Patients: This phase 2 study involved patients with previously treated metastatic colorectal cancer with the KRAS mutation. These patients were divided into three separate treatment groups.
 
958 12.0 months Metastatic colorectal carcinoma 4 Chemotherapy
University Hospital Gasthuisberg Belgium 10/2012
Treatment Details: Patients: This phase 3 study involved metastatic colorectal carcinoma patients who were divided into two separate treatment groups. Group A included 614 patients, 57.5% male, with a median
 
959 12.0 months Advanced Bladder Cancer 4 Biologic therapy
Chemotherapy
Royal Bournemouth Hospital United Kingdom 11/2014
Treatment Details: Patients: This phase 2 study involved 63 previously untreated advanced urothelial carcinoma patients. The median patient age was 64 years and 89% were male. Treatment: Patients receive
 
960 11.9 months Colorectal carcinoma 3 Chemotherapy
Hospital Universitario Central de Asturias Spain 10/2011
Treatment Details: Patients: This study involved colorectal cancer patients who had progressed after previous chemotherapy. Patients were separated into two separate treatment groups. Group A had 38 patient
 
Page 96 of 187  | Previous Page  | Next Page